AngioDynamics (FRA:UG2) Net Income From Continuing Operations : €-178.5 Mil (TTM As of Feb. 2024)

View and export this data going back to 2013. Start your Free Trial

What is AngioDynamics Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. AngioDynamics's net income from continuing operations for the three months ended in Feb. 2024 was €-174.0 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Feb. 2024 was €-178.5 Mil.

AngioDynamics Net Income From Continuing Operations Historical Data

The historical data trend for AngioDynamics's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AngioDynamics Net Income From Continuing Operations Chart

AngioDynamics Annual Data

Trend

May14

May15

May16

May17

May18

May19

May20

May21

May22

May23

Net Income From Continuing Operations

Get a 7-Day Free Trial

54.84

-152.94

-25.96

-25.11

-48.25

AngioDynamics Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
Net Income From Continuing Operations	Get a 7-Day Free Trial															-8.86	-19.75	42.08	-26.84	-174.03

AngioDynamics Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-178.5 Mil.

AngioDynamics (FRA:UG2) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AngioDynamics Inc (FRA:UG2) » Definitions » Net Income From Continuing Operations

Comparable Companies

Traded in Other Exchanges

ANGO:USA UG2:Germany

Address

14 Plaza Drive, Latham, NY, USA, 12110

Website

https://www.angiodynamics.com

AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. It generates maximum revenue from Endovascular Therapies. Geographically, the company derives a majority of its revenue from the United States.

AngioDynamics (FRA:UG2) Headlines

No Headlines